Company intelligence / Profile preview

CK Life Sciences

Hong Kong, Hong Kongck-lifesciences.com ↗

Ownership: Private
Employees: ~1968
Development stage: Other

Overview

CK Life Sciences is advancing a proprietary therapeutic cancer vaccine, seviprotimut-L, for melanoma through its subsidiary Polynoma LLC. The company also invests in liquid biopsy diagnostics for early detection of lung and pancreatic cancers via its strategic stake in Pharus. Other R&D includes novel pain management products and additional diagnostic projects. The company has a broad commercial portfolio in nutraceuticals and agriculture.[1][2][3][7]

Therapeutic areas: Oncology
Modalities: Therapeutic cancer vaccine (Immunotherapy)Small molecule (pain management, nutraceuticals)
Industry: Biotech

Drug pipeline

4 assets

hTROP2 vaccine

Preclinical

3 more assets in the full pipeline.

Request access →

Partnerships

Strategic investment/partnership with Pharus Inc., a US-based liquid biopsy diagnostic companyExclusive license agreement between Pharus Inc. and City of Hope for microRNA biomarker IP relevant to early pancreatic cancer diagnosis

Beyond the preview

Go deeper on CK Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CK Life Sciences.

Explore the full profile